![Dirk Huebner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Huebner
Chief Tech/Sci/R&D Officer at
APTEVO THERAPEUTICS INC.
Net worth: 1 981 $ as of 31/07/2026
Profile
Dirk Huebner is Chief Medical Officer & Senior Vice President at Aptevo Therapeutics, Inc. since 2025.
Formerly, Dr. Huebner was Executive Medical Director at Millennium Pharmaceuticals, Inc. in 2017, Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020, and Vice President at Boston Biomedical, Inc. from 2017 to 2018.
Education includes a doctorate from Freie Universität Berlin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/08/2026 | 482 ( 0.04% ) | 1 981 $ | 31/07/2026 |
Dirk Huebner active positions
| Companies | Position | Start |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Former positions of Dirk Huebner
| Companies | Position | End |
|---|---|---|
| MERSANA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 30/11/2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Corporate Officer/Principal | 01/11/2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/08/2017 |
Training of Dirk Huebner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Commercial Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
- Stock Market
- Insiders
- Dirk Huebner
